2021 2020 2019 Cognition Therapeutics Announces Pricing of Upsized Initial Public Offering Oct 08, 2021 Read More » Cognition Therapeutics Announces Launch of its Initial Public Offering Oct 04, 2021 Read More » Cognition Therapeutics Announces Election of Jack Khattar Chairman of the Board Apr 20, 2021 Read More » Cognition Therapeutics to Present Corporate and Clinical Update at H.C. Wainwright Global Life Sciences Conference Mar 03, 2021 Read More » Cognition Therapeutics Publishes Biomarker Findings from Clinical Study of CT1812 Supporting Positive Impact on Synapse Biology Feb 09, 2021 Read More » Cognition Therapeutics Publishes Evidence Identifying Receptor Integral in Parkinson’s Disease Pathology Feb 01, 2021 Read More » Cognition Therapeutics Reviews 2020 Accomplishments and Provides 2021 Guidance Jan 05, 2021 Read More »
Cognition Therapeutics Announces Election of Jack Khattar Chairman of the Board Apr 20, 2021 Read More »
Cognition Therapeutics to Present Corporate and Clinical Update at H.C. Wainwright Global Life Sciences Conference Mar 03, 2021 Read More »
Cognition Therapeutics Publishes Biomarker Findings from Clinical Study of CT1812 Supporting Positive Impact on Synapse Biology Feb 09, 2021 Read More »
Cognition Therapeutics Publishes Evidence Identifying Receptor Integral in Parkinson’s Disease Pathology Feb 01, 2021 Read More »
Cognition Therapeutics Reviews 2020 Accomplishments and Provides 2021 Guidance Jan 05, 2021 Read More »
